首页> 外文期刊>Therapeutic Drug Monitoring >Development and Validation of a Simple and Rapid UPLC-MS Assay for Valproic Acid and Its Comparison With Immunoassay and HPLC Methods
【24h】

Development and Validation of a Simple and Rapid UPLC-MS Assay for Valproic Acid and Its Comparison With Immunoassay and HPLC Methods

机译:一种简单快速的丙戊酸UPLC-MS分析方法的开发,验证及其与免疫分析和HPLC方法的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Valproic acid (VPA), a widely used antiepileptic drug, has a narrow therapeutic range of 50-100 mcg/mL and shows large individual variability. It is very important to monitor the trough concentration of VPA using a reliable method. Therefore, the aim of this study was to develop and validate a rapid ultraperformance liquid chromatographic-mass spectrometry (UPLC-MS) method for quantification of VPA in human serum and to compare with fluorescence polarization immunoassay (FPIA), chemiluminescence microparticle immunoassay (CMIA), and high-performance liquid chromatography (HPLC) methods.
机译:背景:丙戊酸(VPA)是一种广泛使用的抗癫痫药,治疗范围狭窄,为50-100 mcg / mL,个体差异很大。使用可靠的方法来监测VPA的谷浓度非常重要。因此,本研究的目的是开发和验证一种快速的超高效液相色谱质谱法(UPLC-MS),用于定量测定人血清中的VPA,并与荧光偏振免疫分析法(FPIA),化学发光微粒免疫分析法(CMIA)进行比较。以及高效液相色谱(HPLC)方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号